Literature DB >> 31124200

Efficacy and safety of vismodegib in patients with basal cell carcinoma: An Italian Center experience.

Massimiliano Scalvenzi1, Alessia Villani1, Claudia Costa1, Milena Cappello1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31124200     DOI： 10.1111/dth.12971

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN： 1396-0296            Impact factor:   2.851


× No keyword cloud information.
  2 in total

1.  Treatment of periocular advanced basal cell carcinoma with Hedgehog pathway inhibitors: A single-center study and a new dedicated therapeutic protocol.

Authors:  Vincenzo De Giorgi; Luciana Trane; Giulia Pieretti; Nicola Santoro; Flavia Silvestri; Federico Venturi; Federica Scarfì; Vincenza Maio; Giuseppe Spinelli; Silvia Scoccianti; Laura Guerrini; Daniela Massi; Cinzia Mazzini; Laura Doni
Journal:  Dermatol Reports       Date:  2021-08-05

2.  Long-Term Efficacy of Vismodegib After its Withdrawal and Patients' Health-Related Quality of Life Using the Dermatology Life Quality Index (DLQI).

Authors:  Alessia Villani; Matteo Megna; Gabriella Fabbrocini; Milena Cappello; Maria Antonietta Luciano; Claudia Costa; Massimiliano Scalvenzi
Journal:  Dermatol Ther (Heidelb)       Date:  2019-09-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.